KR970000230A - 염증성 장 질환을 치료하기 위한 캅파-아편제 작용물질 - Google Patents

염증성 장 질환을 치료하기 위한 캅파-아편제 작용물질

Info

Publication number
KR970000230A
KR970000230A KR1019960024568A KR19960024568A KR970000230A KR 970000230 A KR970000230 A KR 970000230A KR 1019960024568 A KR1019960024568 A KR 1019960024568A KR 19960024568 A KR19960024568 A KR 19960024568A KR 970000230 A KR970000230 A KR 970000230A
Authority
KR
South Korea
Prior art keywords
opide
cappa
agonist
treatment
inflammatory bowel
Prior art date
Application number
KR1019960024568A
Other languages
English (en)
Other versions
KR100501612B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR970000230A publication Critical patent/KR970000230A/ko
Application granted granted Critical
Publication of KR100501612B1 publication Critical patent/KR100501612B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
KR1019960024568A 1995-06-28 1996-06-27 염증성장질환을치료하기위한캅파-아편제작용물질 KR100501612B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19523502.9 1995-06-28
DE19523502A DE19523502A1 (de) 1995-06-28 1995-06-28 Kappa-Opiatagonisten für entzündliche Darmerkrankungen

Publications (2)

Publication Number Publication Date
KR970000230A true KR970000230A (ko) 1997-01-21
KR100501612B1 KR100501612B1 (ko) 2005-10-12

Family

ID=7765475

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960024568A KR100501612B1 (ko) 1995-06-28 1996-06-27 염증성장질환을치료하기위한캅파-아편제작용물질

Country Status (26)

Country Link
US (2) US5776972A (ko)
EP (1) EP0752246B1 (ko)
JP (2) JP4415075B2 (ko)
KR (1) KR100501612B1 (ko)
CN (1) CN1119147C (ko)
AR (1) AR004671A1 (ko)
AT (1) ATE214275T1 (ko)
AU (1) AU708699B2 (ko)
BR (1) BR9602915A (ko)
CA (1) CA2179955C (ko)
CO (1) CO4700454A1 (ko)
CZ (1) CZ289805B6 (ko)
DE (2) DE19523502A1 (ko)
DK (1) DK0752246T3 (ko)
ES (1) ES2171577T3 (ko)
HU (1) HU226976B1 (ko)
NO (1) NO309674B1 (ko)
PL (1) PL185537B1 (ko)
PT (1) PT752246E (ko)
RU (1) RU2190401C2 (ko)
SI (1) SI0752246T1 (ko)
SK (1) SK283497B6 (ko)
TR (1) TR199600497A2 (ko)
TW (1) TW430557B (ko)
UA (1) UA51615C2 (ko)
ZA (1) ZA965480B (ko)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239154B1 (en) 1996-03-08 2001-05-29 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US6303611B1 (en) * 1996-03-08 2001-10-16 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US5763445A (en) 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
ATE235903T1 (de) * 1996-12-02 2003-04-15 Kyorin Seiyaku Kk Neue derivate von n-substituierten pyrrolidin derivaten und deren herstellungsverfahren
US6133307A (en) * 1997-04-30 2000-10-17 Warner-Lambert Company Certain benzofuranyl-N-[pyrrolidin-1-YL]-N-methyl-acetamide derivatives useful as opioid agonists
US5760023A (en) * 1997-07-14 1998-06-02 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
WO1999003459A1 (en) * 1997-07-14 1999-01-28 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
DE19827633A1 (de) * 1998-04-20 1999-10-21 Merck Patent Gmbh Verfahren zur Herstellung von enantiomerenreinem N-Methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid
DE10116978A1 (de) * 2001-04-05 2002-10-10 Merck Patent Gmbh Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase
AU2003242527B2 (en) * 2002-05-17 2008-10-23 Tioga Pharmaceuticals, Inc. Use of compounds that are effective as selective opiate receptor modulators
AU2003269399A1 (en) * 2002-11-01 2004-05-25 Pfizer Products Inc. Process for the preparation of pyrrolidinyl ethylamine compounds via a copper-mediated aryl amination
DE10259245A1 (de) * 2002-12-17 2004-07-01 Merck Patent Gmbh Derivate des Asimadolins mit kovalent gebundenen Säuren
TWI334349B (en) * 2003-07-04 2010-12-11 Santen Pharmaceutical Co Ltd Pain threshold reduction depressant
CA2544245A1 (en) * 2003-10-30 2005-05-26 Tioga Pharmaceuticals, Inc. Use of selective opiate receptor modulators in the treatment of neuropathy
US7160902B2 (en) * 2003-11-14 2007-01-09 Adolor Corporation Amide derivatives and methods of their use
US7642274B2 (en) 2004-07-02 2010-01-05 Santen Pharmaceutical Co., Ltd. Inhibitor of pain threshold decrease
EP2136801B1 (en) * 2007-03-30 2012-08-29 Tioga Pharmaceuticals, Inc. Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome
JP6138169B2 (ja) * 2012-03-05 2017-05-31 ドクター レディズ ラボラトリーズ リミテッド κオピオイド受容体（ＫＯＲ）アゴニストとしての置換複素環式アセトアミド
MX2016009624A (es) * 2014-01-24 2016-11-08 Cadila Healthcare Ltd Compuestos heterobiciclicos novedosos como agonistas del opioide kappa.
WO2018119108A1 (en) 2016-12-21 2018-06-28 Tioga Pharmaceuticals Inc. Splid pharmaceutical formulations of asimadoline
WO2019122361A1 (en) 2017-12-22 2019-06-27 Dr. August Wolff Gmbh & Co. Kg Arzneimittel Asimadoline for use in treating pulmonary diseases, vascular diseases, and sepsis
EP3932390A1 (en) 2020-07-02 2022-01-05 Dr. August Wolff GmbH & Co. KG Arzneimittel Topical gel formulation containing asimadoline

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663343A (en) * 1985-07-19 1987-05-05 Warner-Lambert Company Substituted naphthalenyloxy-1,2-diaminocyclohexyl amide compounds
DE4034785A1 (de) * 1990-11-02 1992-05-07 Merck Patent Gmbh 1-(2-arylethyl)-pyrrolidine
US5232978A (en) * 1988-12-23 1993-08-03 Merck Patent Gesellschaft Mit Beschrankter Haftung 1-(2-arylethyl)-pyrrolidines
CA2021817C (en) * 1989-07-24 2000-09-26 William J. Mork Upholstered article of furniture with interchangeable seating module
DE4215213A1 (de) * 1992-05-09 1993-11-11 Merck Patent Gmbh Arylacetamide

Also Published As

Publication number Publication date
JP4415075B2 (ja) 2010-02-17
DK0752246T3 (da) 2002-05-13
AR004671A1 (es) 1999-03-10
KR100501612B1 (ko) 2005-10-12
UA51615C2 (uk) 2002-12-16
PL314996A1 (en) 1997-01-06
NO962720L (no) 1996-12-30
ATE214275T1 (de) 2002-03-15
US5776972A (en) 1998-07-07
CA2179955A1 (en) 1996-12-29
TR199600497A2 (tr) 1997-01-21
PL185537B1 (pl) 2003-05-30
JP5308056B2 (ja) 2013-10-09
NO309674B1 (no) 2001-03-12
SK283497B6 (sk) 2003-08-05
HU226976B1 (en) 2010-04-28
JP2008201794A (ja) 2008-09-04
CZ289805B6 (cs) 2002-04-17
EP0752246A2 (de) 1997-01-08
CZ186696A3 (en) 1997-01-15
ZA965480B (en) 1997-01-27
CA2179955C (en) 2008-10-07
US5977161A (en) 1999-11-02
CN1145781A (zh) 1997-03-26
TW430557B (en) 2001-04-21
DE19523502A1 (de) 1997-01-02
PT752246E (pt) 2002-09-30
HUP9601798A1 (hu) 1998-03-30
SI0752246T1 (en) 2002-10-31
AU5616296A (en) 1997-01-09
CN1119147C (zh) 2003-08-27
EP0752246A3 (de) 1997-02-26
NO962720D0 (no) 1996-06-27
EP0752246B1 (de) 2002-03-13
RU2190401C2 (ru) 2002-10-10
BR9602915A (pt) 1998-04-22
JPH0920659A (ja) 1997-01-21
SK84396A3 (en) 1997-04-09
DE59608861D1 (de) 2002-04-18
CO4700454A1 (es) 1998-12-29
ES2171577T3 (es) 2002-09-16
AU708699B2 (en) 1999-08-12

Similar Documents

Publication Publication Date Title
KR970000230A (ko) 염증성 장 질환을 치료하기 위한 캅파-아편제 작용물질
ATE241977T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
DE69626151D1 (de) Endoskop
DE29503478U1 (de) Endoskop
NO20012995L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO975690L (no) Fremgangsmåte for forbedring av dyrehelse
DE69536043D1 (de) Doppelseitige bilderzeugung
DE69728951D1 (de) Bilderzeugungsverfahren
BR9607235A (pt) Sulfonilaminocarboniltriazolinonas tendo substituintes de halogenoalquiltio
DE69632526D1 (de) Multiplexerschaltung
DE69634464D1 (de) Cachespeicher
DE9404033U1 (de) Urinier-Hilfe
DE69612813T2 (de) Bildherstellungsverfahren
DE69614600T2 (de) Bilderzeugungsverfahren
DE9415180U1 (de) Sanitär-Vorwand
DE69634465D1 (de) Cachespeicher
DE69518474T2 (de) Frühzeitige Arbitrierung
KR970039066U (ko) 과도금 방지장치
KR960029102U (ko) 가족 납골묘
DE29501643U1 (de) Kondom
KR960030462U (ko) 콘돔
KR970020851U (ko) 콘돔
KR960033026U (ko) 모니터의 조정장치
KR960033544U (ko) 환자용 배뇨기
KR960036308U (ko) 위생용 콘돔

Legal Events

Date Code Title Description
A201 Request for examination
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
J201 Request for trial against refusal decision
AMND Amendment
B90T Transfer of trial file for re-examination
E902 Notification of reason for refusal
B701 Decision to grant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120620

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20130620

Year of fee payment: 9

LAPS Lapse due to unpaid annual fee